MCS+ 08150-110-E
MCS+ 08150-110-E is an apheresis system (FDA Class II; FDA product code GKT, Separator, automated, blood cell, diagnostic) made by Haemonetics Corporation, listed under FDA premarket submission BK040041 (2 earlier submissions) and listed in FDA GUDID since 6 Feb 2017 (UDI-DI 30812747013875), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
510(k) BK040041
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number30812747013875 | Date6 Feb 2017 | StatusListed |
| United States | FDA 510(k) | NumberBK040041 | Date— | StatusActive |
Official records
- AccessGUDID record 30812747013875
From the FDA record
- Device description
- MCS+ (RBC), LIST NO 08150-110-E
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA premarket submission BK040041 Active
- FDA GUDID UDI-DI 30812747013875 listed 6 Feb 2017 Listed
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Mcs+
- Generic name
- Apheresis system
- Model / reference
- 08150-110-E
- Primary DI / UDI-DI
- 30812747013875
- FDA product code
- GKT
- GMDN term
- Apheresis system
- Device class
- Class II
- Regulation number
- 864.9245
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Apheresis system.